Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Scope</h3><p>To investigate the effect of Qingjie Fuzheng Granule (QFG) on lymphangiogenesis and lymphatic metastasis in colorectal cancer.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>The effects of QFG on the expression and secretion of vascular endothelial growth factor-C (VEGF-C) in HCT-116 cells were investigated both <em>in vitro</em> and <em>in vivo</em>. HCT-116 cells were treated with different concentrations (0.2, 0.5, and 1.0 mg/mL) of QFG. The VEGF-C expression level was determined using RT-qPCR and western blotting, and the VEGF-C concentration in supernatant was measured by ELISA. Tumor xenograft models of HCT-116 cells were generated using BALB/c nude mice, and the mice were randomly divided into a control group (gavaged with normal saline) and QFG group (gavaged with 2 g/kg QFG). The effect of QFG on tumor growth was evaluated by comparing the volume and weight of tumors between two groups. Immunohistochemistry (IHC) and RT-qPCR were performed to detect the expression levels of VEGF-C, vascular endothelial growth factor receptor 3 (VEGFR-3), and LYVE-1 (lymphatic vessel endothelial hyaluronan receptor 1). ELISA was performed to measure the concentration of serum VEGF-C. TMT proteomics technology and Reactome pathway analysis were used to explore the mechanism of QFG inhibiting lymphangiogenesis in tumor. The VEGF-C (5 ng/mL)-stimulated human lymphatic endothelial cell (HLEC) model was conducted to evaluate the effect of QFG on lymphangiogenesis <em>in vitro</em>. The model cells were treated with different concentrations (0.2, 0.5, and 1.0 mg/mL) of QFG. Cell viability was then determined using an MTT assay. The cell migration, invasion, and tube-formation ability were analyzed using transwell migration, matrigel invasion and tube formation assays, respectively. The underlying mechanism was uncovered, the levels of VEGFR-3, matrix metalloproteinase 2 (MMP-2), matrix metalloproteinase 9 (MMP-9), p-PI3K/PI3K, p-AKT/AKT and p-mTOR/ mTOR were detected using western blotting.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>QFG significantly reduced VEGF-C expression and secretion in HCT-116 cells. QFG evidently suppressed <em>in vivo</em> tumor growth and the expression of VEGF-C, VEGFR-3, and LYVE-1. The serum VEGF-C level was also reduced by QFG. Moreover, TMT proteomics technology and Reactome pathway analysis identified 95 differentially expressed protein and multiple enriched pathway about matrix metalloproteinase and extracellular matrix, which is direct associate with lymphangiogenesis. <em>In vitro</em> experiment, QFG inhibited the viability, migration, invasion and tube formation of HLECs. Additionally, QFG reduced the VEGFR-3, MMP-2, MMP-9 expression levels, and the p-PI3K/PI3K, p-AKT/AKT, p-mTOR/ mTOR ratios.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusion</h3><p>QFG can exert its effect on both tumor cells and HLECs, exhibiting ani- lymphangiogenesis in colorectal cancer <em>via</em> the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway pathway.</p>

Effect of Qige Fang (启膈方) on Expression of Eca109, TE13 and Cx26 in Human Esophageal Carcinoma Cells

Effect of Qigesan on the Cell -cell Adhesion of Esophageal Cancer

Effect of Qigesan on the Rearrangement of the Actin Cytoskeleton in Esophageal Cancer Cells

Qigefang Inhibits Migration, Invasion, and Metastasis of ESCC by Inhibiting Gas6/Axl Signaling Pathway

Qigesan inhibits esophageal cancer cell invasion and migration by inhibiting Gas6/Axl-induced epithelial-mesenchymal transition

Qigesan Inhibits Migration and Invasion of Esophageal Cancer Cells Via Inducing Connexin Expression and Enhancing Gap Junction Function.

Qigesan Reduces the Motility of Esophageal Cancer Cells Via Inhibiting Gas6/Axl and NF-κB Expression

[Effect of PC Cell-Derived Growth Factor RNA Interference on Biological Behavior of Esophageal Squamous Carcinoma Cells].

Effect of resveratrol on the invasion migration of Eca-109 cells and epithelial-mesenchymal transition in esophageal squamous cell carcinoma

Effect of Modified Qigesan on the Recurrence and Metastasis Rate and Quality of Life among Patients after Radical Resection of Esophageal Carcinoma

Effects of Shenqi Fuzheng injection on the invasiveness of cells and expression of Tenascin-C in human gastric cancer MGC-803 cells

Effect of 2-[(3-carboxy-1-oxoprogyl) Amino]-2-deoxy-d-glucose on Esophageal Cancer in Nude Mice and Expression of Its Relational Genes

Effect of HIF-1αby RNAi on Radiosensitivity in Esophageal Squamous Carcinoma Cell Line Eca109 under Hypoxia

The Effect of Chinese herbal medicine in the treatment of lung and esophagus cancer treated with radiotherapy

FAM83D promotes the progression of 4NQO-induced esophageal carcinoma via inhibiting FBWX7

Qingjie Fuzheng Granule suppresses lymphangiogenesis in colorectal cancer via the VEGF-C/VEGFR-3 dependent PI3K/AKT pathway

Expression of AEG - 1 and PI3K in esophageal squamous carcinoma cell and relation-ship with clinicopathological features and prognosis

Molecular mechanism of epigallocatechin-3-gallate in human esophageal squamous cell carcinoma in vitro and in vivo.

Effect of 1,25-Dihydroxyvitamin D3 Combined with 5-Fluorouracil on IGFBP-3 Expression in Human Esophageal Carcinoma 109 Cell Xenograft in Nude Mice

[Inhibitory Effect and Mechanism of (-)-epigallocatechin-3-gallate on HT29 and HCT-8 Colorectal Cancer Cell Lines and Expression of HES1 and JAG1].

Influence of "qiyeling Granule" on Apoptosis of Lewis Lung Cancer and MMP9 Expression in C57 Mice